Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Massachusetts governor roils PhRMA with law on drug firm payments

This article was originally published in Scrip

Executive Summary

Massachusetts Governor Deval Patrick was in the spotlight earlier this summer when he signed into law a bill that invests $1 billion over 10 years in the state's life sciences community. Now just two months later he is facing the wrath of BIO, PhRMAand the Massachusetts Biotechnology Council (MBC) with the signing of a bill that contains language that will force companies to disclose any gifts or payments over $50 that they provide to doctors – and which all of the groups believe will interfere with collaborations that have been essential to the expansion of this sector in the state.

Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts